This document discusses limitations of Lewis acid-base reactions, properties of buffer solutions, buffer capacity, the Henderson-Hasselbalch equation, and applications of buffers in pharmacy. It also covers general principles for adjusting solutions to isotonicity and its importance, types of impurities found in pharmaceutical substances, sources of impurities, effects of impurities, and limit tests for chloride, sulfate, iron, heavy metals, lead, and arsenic. Limit tests are used to identify and control small quantities of impurities that may be present in substances.
Limit tests, Introduction, Definition,
Limit Test For Chlorides
Limit Test For Sulphates
Limit Test For Iron
Limit Test For Lead
Limit Test For Arsenic
The need for non aqueous titration arises because water can behave as a weak base and a weak acid as well, and can hence compete in proton acceptance or proton donation with other weak acids and bases dissolved in it.
Limit tests, Introduction, Definition,
Limit Test For Chlorides
Limit Test For Sulphates
Limit Test For Iron
Limit Test For Lead
Limit Test For Arsenic
The need for non aqueous titration arises because water can behave as a weak base and a weak acid as well, and can hence compete in proton acceptance or proton donation with other weak acids and bases dissolved in it.
Introduction to limit tests, the limit test is a semiquantitative test, limit test for chlorides, limit test for sulfates, limit test for iron, limit test for heavy metals, limit test for arsenic, Gutzeit apparatus
Non Aqueous Titration
Types of solvents used in non aqueous Titration
Compounds used for non aqueous Titration
Titration done for weak acid and weak base,
INTRODUCTION TO PHARMACEUTICAL CHEMISTRY AND LIMIT TESTSUJATA WANKHEDE
INTRODUCTION TO PHARMACEUTICAL CHEMISTRY, INTRODUCTION TO LIMIT TESTS, LIMIT TEST OF IRON, CHLORIDE, SULPHATE, ARSENIC AND THERE DIAGRAMS WITHTHE PRINCIPAL AND PROCEDURE OF ALL THE LIMIT TEST WITH THEIR RESULTS
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test.
Limit tests:- Factors affecting limit tests:
Specificity of the tests
Sensitivity
Control of personal errors (Analyst errors)
Test in which there is no visible reaction
Comparison methods
Quantitative determination
Limit test for Chloride: Principle, Procedure, observation and result.
Limit test for Sulphate: Principle, Procedure, observation and result
Limit test for Iron: Principle, Procedure, observation and result.
Limit test for Heavy metal: Principle, Procedure, observation and result.
Limit test for Lead: Principle, Procedure, observation and result.
Limit test for Arsenic: Principle, Gutzet test Procedure, detail in Gutzet Apparatus. observation and result.
Modifies Limit test for Chloride: Principle, Procedure, observation and result.
Modified Limit test for sulphate: Principle, Procedure, observation and result.
Learning objectives
Introduction
Types of solvents
Acidimetry in non aqueous medium
Alkalimetry in non aqueous medium
Estimation of Sodium benzoate and Ephedrine HCl
Applications of non aqueous titrations in pharmacy
Conclusion
Reference
In this ppt the viewer will able to know about different methods for the protein analysis. Proteins are long chain of amino acids and there are specific test also required depends on the nature and structure of proteins. As the name suggest amino acids are organic compounds that contain amino and carboxyl groups. The R- in the formulas stands for different chemical groups (may be aliphatic, aromatic or heterocycylic) and this determines the characteristics of the amino acids. The colour tests have frequently been used for qualitative detection of amino acids. Not all amino acids contain the same reactive groups. For this reason the various colour tests yield reactions varying in intensity and type of colour according to the nature of groups contained in the particular amino acid under examination.
• Portion explained:
• Detection of Proteins
1. Millon’s reaction
2. Millon-Nasse reaction
3. Xanthoproteic reaction
4. Hopkins-Cole reaction
5. Biuret test
6. Ninhydrin reaction
7. Folin test
8. Sakaguchi test
9. Nitroprusside test
10. Spectrophometric method
Non aqueous titration refers to a type of titration in which the analyte substance is dissolved in a solvent which does not contain water. This procedure is a very important one in pharmacopoeial assays.
Introduction to limit tests, the limit test is a semiquantitative test, limit test for chlorides, limit test for sulfates, limit test for iron, limit test for heavy metals, limit test for arsenic, Gutzeit apparatus
Non Aqueous Titration
Types of solvents used in non aqueous Titration
Compounds used for non aqueous Titration
Titration done for weak acid and weak base,
INTRODUCTION TO PHARMACEUTICAL CHEMISTRY AND LIMIT TESTSUJATA WANKHEDE
INTRODUCTION TO PHARMACEUTICAL CHEMISTRY, INTRODUCTION TO LIMIT TESTS, LIMIT TEST OF IRON, CHLORIDE, SULPHATE, ARSENIC AND THERE DIAGRAMS WITHTHE PRINCIPAL AND PROCEDURE OF ALL THE LIMIT TEST WITH THEIR RESULTS
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test.
Limit tests:- Factors affecting limit tests:
Specificity of the tests
Sensitivity
Control of personal errors (Analyst errors)
Test in which there is no visible reaction
Comparison methods
Quantitative determination
Limit test for Chloride: Principle, Procedure, observation and result.
Limit test for Sulphate: Principle, Procedure, observation and result
Limit test for Iron: Principle, Procedure, observation and result.
Limit test for Heavy metal: Principle, Procedure, observation and result.
Limit test for Lead: Principle, Procedure, observation and result.
Limit test for Arsenic: Principle, Gutzet test Procedure, detail in Gutzet Apparatus. observation and result.
Modifies Limit test for Chloride: Principle, Procedure, observation and result.
Modified Limit test for sulphate: Principle, Procedure, observation and result.
Learning objectives
Introduction
Types of solvents
Acidimetry in non aqueous medium
Alkalimetry in non aqueous medium
Estimation of Sodium benzoate and Ephedrine HCl
Applications of non aqueous titrations in pharmacy
Conclusion
Reference
In this ppt the viewer will able to know about different methods for the protein analysis. Proteins are long chain of amino acids and there are specific test also required depends on the nature and structure of proteins. As the name suggest amino acids are organic compounds that contain amino and carboxyl groups. The R- in the formulas stands for different chemical groups (may be aliphatic, aromatic or heterocycylic) and this determines the characteristics of the amino acids. The colour tests have frequently been used for qualitative detection of amino acids. Not all amino acids contain the same reactive groups. For this reason the various colour tests yield reactions varying in intensity and type of colour according to the nature of groups contained in the particular amino acid under examination.
• Portion explained:
• Detection of Proteins
1. Millon’s reaction
2. Millon-Nasse reaction
3. Xanthoproteic reaction
4. Hopkins-Cole reaction
5. Biuret test
6. Ninhydrin reaction
7. Folin test
8. Sakaguchi test
9. Nitroprusside test
10. Spectrophometric method
Non aqueous titration refers to a type of titration in which the analyte substance is dissolved in a solvent which does not contain water. This procedure is a very important one in pharmacopoeial assays.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. Limitations of Lewis
• As lewis acid base reactions involve electrons,
they are expected to be very fast reactions.
However there are many lewis acid-base
reactions which are slow
3. Properties of Buffer solutions
1.pH remain constant
2.pH does not change on dilution
3.pH doesn’t change even after addition of
small quantities of acids or bases
4.Constant pH: Useful in number of
chemical reactions
5.pH does not change on keeping for long
time
Buffer Solutions: Solutions that are able to resist the
changes in pH values
4. Buffer capacity- Amount of acid/ Base
that must be added to the buffer to
produce a unit change of pH
5. Significance of Henderson-Hasselbalch
equation
• pH of buffer solution can be calculated
• Dissociation constant of an acid (pKa) can be
calculated
• Dissociation constant of an base (pKb) can be
calculated
6. Applications of buffers in pharmacy
1.Solubility- Solubility of compounds can
be frequently controlled by providing a
medium of suitable pH.
Eg. Inorganic salts (Phosphates)- soluble in
acidic media and precipitate in basic media
2. Color- Color of many dyes are pH
dependant
Eg. Red color of cherry maintained at
acidic pH
7. Applications of buffers in pharmacy
(NR)
3. Stability of certain compounds
Eg. Penicillin-unstable in alkaline pH
4. Some compounds structurally unstable
at certain pH ranges
Eg. Nitrites become brown in acidic media
due to formation of nitrogen oxide
5. Patient comfort- Injectables/ internal or
external preparations are irritating if pH is
different from normal
8. Applications of buffers in pharmacy
6. Medicinal compounds activity-
Optimum pH is maintained
Eg. Buffering methenamine with sodium
dihydrogen phosphate
7. Analytical lab- buffers of known pH
used as standard
9. General Principles for adjusting
isotonicity and its importance
• Solutions for i/v injection: Approximate
isotonicity is always desirable
• Solutions for s/c injection: Isotonicity is
needed but it is not essential since they are
injected into fatty tissues and not in blood
stream
• Solutions for i/m injection: The aqueous
solutions should be slightly hypertonic to
promote rapid absorption
10. • Solutions for intra-cutaneous injection: The
parenteral preparations which are meant for
diagnostic pupose should be isotonic in order to
avoid false reaction
• Solutions for intrathecal injection: these must be
isotonic, because volume of C.S.F (cerebrospinal
fluid) is only 60 to 80 mL. Hence, a small volume
of paratonic solution will disturb the osmotic
pressure and may cause vomiting and other side-
effects.
11. • Solutions used for nasal drops: Isotonicity is
needed, since paratonic solution may cause
irritation
• Solutions used as eye drops and eye lotions:
Eye lotion should be isotonic with lachrymal
secretion, since a large volume is brought in
contact with the eye. Eye drops may not be
isotonic because only a small volume is used
quickly get diluted by the lachrymal secretion.
12. Isotonicity –concept and importance
• Osmosis- Diffusion of solvent through a semi-
permeable membrane from less concentrated
solution to higher concentrated solution.
• Osmotic Pressure- The pressure needed to stop
the osmotic flow [It stops the flow of solvent
molecules from a dilute solution to a
concentrated solution]
• Tonicity- Measure of the osmotic pressure of two
solutions separated by a semi-permeable
membrane
13. Isotonicity –concept and importance
• Isotonic solutions- A solution having the same
solute concentration as in a cell/ Body fluid
[A solution containing 0.9% NaCl is isotonic with
blood plasma and is regarded as standard]
• Iso-osmotic solutions-Two solutions having
the same osmotic pressure
• Paratonic solutions- Solutions which are not
having the same osmotic pressure
15. Calculations for adjustment to
isotonicity
1. Based on Freezing point-
% w/v of adjusting substance needed= (0.52-a)/b
a= F.P of unadjusted solution
b= F.P of 1% w/v solution of adjusting substance
2. Based on molecular concentration
% w/v of adjusting substance needed= (0.03M/N
M= Gram molecular weight of the substance
N= No. of ions into which the substance is ionized
16. Examples
Q1. Find the concentration of sodium chloride
required to make a 1 percent solution of boric
acid, iso-osmotic with blood plasma.
Given- The F.P of 1% w/v solution of boric acid
is 0.288 °C. The F.P of 1% w/v solution of Nacl
is 0.576 °C.
17. Q2. Find the concentration of Nacl
required to produce a solution iso-
osmatic with blood plasma.
18. Q3. Find the proportion of dextrose
needed to form a solution iso-osmotic
with blood plasma.
19. Q4. Find out the proportion of
procaine hydrochloride which will yield
a solution iso-osmotic with blood
plasma
F.P of procaine hydrochloride is 0.122
21. Types of impurities found in medicinal
preparations
Impurity: A compound is said to be impure if it is having foreign
matter i.e impurities
1. The impurities which are having a toxic effect when present
beyond certain limits (eg lead and arsenic salts)
2. The impurities which otherwise are harmless but lowers the
therapeutic activity of pure substance.
3. The impurities which are able to lessen the keeping properties
of the substance
4. The impurities which are able to make the substance
incompatible with other substances
5. The impurities which can be easily detected by the senses like
taste, odor, color or appearance (eg. Sodium salicylate is
usually discolored due to phenolic impurities)
22. Effects of impurities
1. Impurities can be injurious when present above certain limits
2. Impurities even present in traces may exert a cumulative
toxic effect after a certain period
3. If impurities are present in large proportions , they lowers
the therapeutic activity of the substance
4. Impurities may change the physical and chemical properties
of the substance
5. Impurities may bring about technical difficulties in the
formulation
6. Impurities may cause incompatibility with other substances
7. Impurities may decrease the shelf life of the substance
8. Impurities may change color, odor, taste etc.
23. Sources of impurities
1.Raw materials employed in
manufacturing
For eg. Cu turnings are known to
have iron and arsenic as impurities
24. 2. Reagents used in the manufacturing
process
For eg The solid precipitate is washed
with water to remove excess of
sodium carbonate and soluble
chlorides as impurities
25. 3. Method or the process used in
manufacture
a)Reagents employed in the process- Soluble alkali
in calcium carbonate arises from sodium
carbonate
b. Solvents- Tap water is having Ca2+ ,Mg2+ ,Na+
,Cl- ,SO42- , CO32- as impurities in very small
amount
26. 4. Chemical processes used in the
manufacture
Tap water is used in various processes and has
chloride, calcium and magnesium which may find
access to the substance being manufactured
5. Atmospheric contamination during
the manufacturing process
For eg. Sodium hydroxide absorbs
atmospheric carbon dioxide
27. 6. Intermediate products in the manufacturing
process- if the intermediate product KIO3 is not
completely converted to KI, then it may be
carried through to the final product as an
impurity
28. 7. Defects in the manufacturing
process
If there is lesser heat or air or both, zinc metal
is not completely converted into zinc oxide thus
the final product ZnO may still contain metallic
zinc as impurity
30. 9. Storage conditions
• Filth
• Chemical instability
• Reaction with container
materials
• Physical changes
• Temperature effects
31. 10. Decomposition of the product
during storage
Many organic substances get
spoiled due to decomposition
on exposure to the atmosphere
eg amines, phenols
32. 11. Accidental substitution or delibrate
adulteration with spurious or useless
materials
KBr may be adulterated with
cheaper sodium bromide
33. LIMIT TESTS
Limit tests are quantitative or semi-
quantitative tests designed to identify and
control small quantities of impurity which
are likely to present in the substance
34. Limit test for Chloride
Basic reaction:
Soluble
Chlorides
Silver
nitrate
HNO3
• Silver
chloride
• Turbidity
35. Sample pass the limit test if turbidity
of sample is less than the standard
turbidity
TEST SOLUTION STANDARD SOLUTION
Specified substance (1g) + H20 (10mL) 0.05845 % w/v Solution of NaCl (1mL)
Add HNO3 (1mL) Add HNO3 (1mL)
Upto 50 mL (With H2O) Upto 50 mL (With H2O)
Add AgNO3 (1mL) Add AgNO3 (1mL)
Stirr and Kept aside for 5min, compare
opalescence with standard
Kept aside for 5min, compare
opalescence with sample
36. Limit test for Sulphate
Basic reaction:
Dil
HCL
Soluble
sulphates
Barium
chloride
• BaCL2 is replaced by BaSO4 reagent in IP (Modified
limit test for Sulphate)
• BaSO4 reagent- BaCl2 + Sulphate free alcohol+ Solution
of potassium sulphate
• Sulphate free alcohol- Prevents super saturation and
produce more uniform opalescence
• Potassium Sulphate- Increase sensitivity of the test
37. Sample pass the limit test if turbidity
of sample is less than the standard
turbidity
TEST SOLUTION STANDARD SOLUTION
Specified substance (1g) 0.1089 % w/v Solution of K2SO4 (1mL)
Add HCL(2mL) Add HCL(2mL)
Upto 45 mL (With H2O) Upto 45 mL (With H2O)
Add BaSO4 reagent (5mL) Add BaSO4 reagent (5mL)
Stirr and Kept aside for 5min, compare
opalescence with standard
Stirr and Kept aside for 5min, compare
opalescence with sample
38. Limit test for IRON
Citric acid In the
ammonical alkaline
medium
Basic reaction
• Purple color Chelate
because of Fe
• Colorless in acidic or
neutralization solutions
39. Principle
Iron in ammonical
solution
+ Citric acid
(20%)
• Doesn’t allow
precipitation of
iron by ammonia
by forming a
complex with it
• Eliminate
interference of
other metal
cations
+ Thioglycollic acid
• Colorless,
unpleasant odor
• More sensitive
Pale pink to deep
reddish purple
color is formed
due to ferrous
compounds
40. Sample pass the limit test if color of sample is
less dark than the color of standard
TEST SOLUTION STANDARD SOLUTION
Specified substance (1g) [NaCl] Standard solution of Iron/ Ferric
ammonium sulphate i.e. 2mL [NH4Fe
(SO4)2.12H2O], 0.173 g + HCL (1.5mL),
Volume makeup upto 1000 mL using H2O
Add water (40 mL) Add water (40mL)
+ 20% w/v Iron free citric acid (2mL) + 20% w/v Iron free citric acid (2mL)
Add Thioglycollic acid (2drops) Add Thioglycollic acid (2drops)
• Made alkaline with Iron free ammonia
• Volume makeup upto 50 ml using
water
• Allow to stand and compare with
standard
• Made alkaline with Iron free ammonia
• Volume makeup upto 50 ml using
water
• Allow to stand and compare with
sample
41. Limit test for heavy metals
[lead, mercury, bismuth, arsenic,
antimony, tin, cadmium, silver, copper,
molybdenum]
42.
43.
44. Sample pass the limit test if color of
sample is less intense than the color of
standard
TEST SOLUTION STANDARD SOLUTION
25 mL of solution prepared for the test as
directed in the individual monograph or
dissolve the specified quantity of the
substance under examination in a
mixture of 20mL of water
20 ppm lead standard solution (1mL)
Add dil NaoH (5mL) Add dil NaoH (5mL)
Volume makeup Upto 50mL (H2O) Volume makeup Upto 50mL (H2O)
Sodium sulphide solution (5drops) Sodium sulphide solution (5drops)
Allow to stand for 5min and view
downwards over a white surface
Allow to stand for 5min and view
downwards over a white surface
45. Limit test for Lead
Expressed as parts of lead per million parts of the substance under examination
46. The color of the chloroform layer should not be more intense than standard solution
47. TEST SOLUTION STANDARD SOLUTION
Transfer sample solution into separator/
separating funnel
1 ppm lead standard solution
Add Ammonium citrate solution Sp. (6mL) * For
Iron salts (10mL)
Add Ammonium citrate solution Sp. (6mL) * For
Iron salts (10mL)
Hydroxylamine Hydrochloride solution Sp.
(2mL)
Hydroxylamine Hydrochloride solution Sp.
(2mL)
• Phenol red solution (2drops)
• Make solution alkaline and red in color
(Strong ammonia solution)
• Potassium cyanide solution Sp. (2mL)
• Extract the above solution with dithizone
solution (5 ml for each time)until the
dithizone extraction solution retain it
become green
• 1% v/v Nitric acid (30mL)
• Discard the chloroform layer
• Shake the combine dithiazone solution for
30 seconds
• Dithizone solution (5mL) and shake for 30
seconds
• Phenol red solution (2drops)
• Make solution alkaline and red in color
(Strong ammonia solution)
• Potassium cyanide solution Sp. (2mL)
• Extract the above solution with dithizone
solution (5 ml for each time)until the
dithizone extraction solution retain it
become green
• 1% v/v Nitric acid (30mL)
• Discard the chloroform layer
• Shake the combine dithiazone solution for
30 seconds
• Dithizone solution (5mL) and shake for 30
seconds
48.
49. Limit test for Arsenic
• Indicated in terms of ppm i.e parts of
arsenic as per million parts (by weight )
of the substance
• Apparatus:
• Conical flask closed with stopper through
which passes a lower glass tube ( insert
50-60mg of lead acetate cotton)
• A second glass tube is placed in contact
with the first and is held in position by
clips
• Between the flat surfaces of the tubes
place a disc of mercuric chloride
50. TEST SOLUTION STANDARD SOLUTION
Test solution 10 ppm Arsenic standard solution
diluted to 50ml water (1mL)
Add 1M KI (5mL) + Zinc AsT (10g) Add 1M KI (5mL) + Zinc AsT (10g)
Assemble the apparatus, immerse the
flask in water bath at a temperatures
such that a uniform evolution of a gas is
maintained
Assemble the apparatus, immerse the
flask in water bath at a temperatures
such that a uniform evolution of a gas is
maintained
After 40min any stain on the mercuric
chloride paper should not be more
intense than the standard solution
After 40min any stain on the mercuric
chloride paper should not be more
intense than the standard solution